{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:38:51Z","timestamp":1772271531824,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Motorcycle Ride for Dad"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.clon.2017.01.042","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T21:15:20Z","timestamp":1486674920000},"page":"412-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"N.","family":"Shahid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Loblaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Szumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Danjoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sankreacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Deabreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mamedov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7326\/0003-4819-155-3-201108020-00347","article-title":"Comparative evaluation of radiation treatments for clinically localized prostate cancer: an updated systematic review","volume":"155","author":"Bannuru","year":"2011","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.radonc.2013.05.002","article-title":"GEC\/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update","volume":"107","author":"Hoskin","year":"2013","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5114\/jcb.2014.45759","article-title":"High-dose-rate brachytherapy boost for prostate cancer: rationale and technique","volume":"6","author":"Morton","year":"2014","journal-title":"J\u00a0Contemp Brachyther"},{"issue":"4","key":"10.1016\/j.clon.2017.01.042_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.brachy.2010.02.196","article-title":"Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT","volume":"9","author":"Deutsch","year":"2010","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.clon.2017.01.042_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2017.01.042_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.radonc.2008.02.023","article-title":"Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy","volume":"88","author":"Pieters","year":"2008","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2017.01.042_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brachy.2009.04.007","article-title":"High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer","volume":"9","author":"Zwahlen","year":"2010","journal-title":"Brachytherapy"},{"issue":"6","key":"10.1016\/j.clon.2017.01.042_bib8","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2005.06.154","article-title":"Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate","volume":"23","author":"Sathya","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2014.11.018","article-title":"Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis","volume":"91","author":"Smith","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2017.01.042_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2013.05.038","article-title":"Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up","volume":"108","author":"Ferrer","year":"2013","journal-title":"Radiother Oncol"},{"issue":"31","key":"10.1016\/j.clon.2017.01.042_bib11","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1200\/JCO.2009.25.3245","article-title":"Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment","volume":"28","author":"Pardo","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.clon.2017.01.042_bib12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.clon.2017.01.042_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.radonc.2015.02.023","article-title":"High dose-rate brachytherapy boost for intermediate risk prostate cancer: long-term outcomes of two different treatment schedules and early biochemical predictors of success","volume":"115","author":"Helou","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib14","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.radonc.2011.08.022","article-title":"Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?","volume":"100","author":"Morton","year":"2011","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib15","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.ijrobp.2010.04.046","article-title":"Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer","volume":"80","author":"Morton","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.clon.2013.01.001","article-title":"Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy","volume":"25","author":"Hoskin","year":"2013","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: a systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"10.1016\/j.clon.2017.01.042_bib19","first-page":"974","article-title":"Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors","volume":"169","author":"Martinez","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib20","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2004.08.014","article-title":"High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results","volume":"61","author":"Demanes","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2017.01.042_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2007.05.019","article-title":"Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I\/II study results","volume":"84","author":"Duchesne","year":"2007","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.brachy.2011.01.003","article-title":"Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients","volume":"10","author":"Agoston","year":"2011","journal-title":"Brachytherapy"},{"issue":"16","key":"10.1016\/j.clon.2017.01.042_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S1470-2045(15)00280-6","article-title":"Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"16","author":"Wilkins","year":"2015","journal-title":"Lancet Oncol"},{"issue":"S3","key":"10.1016\/j.clon.2017.01.042_bib24","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.ijrobp.2015.07.289","article-title":"Toxicity outcome in ASCENDE-RT: a multicenter randomized trial of dose-escalation trial for prostate cancer","volume":"93","author":"Rodda","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"S7","key":"10.1016\/j.clon.2017.01.042_bib25","first-page":"33","article-title":"ASCENDE-RT: a multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer","author":"Morris","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.clon.2017.01.042_bib26","first-page":"2206","article-title":"Health related quality of life for men treated for localized prostate cancer with long-term followup","volume":"183","author":"Huang","year":"2010","journal-title":"J\u00a0Urol"},{"issue":"9","key":"10.1016\/j.clon.2017.01.042_bib27","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/bjc.2013.181","article-title":"Quality of life after prostate cancer treatments in patients comparable at baseline","volume":"108","author":"van Tol-Geerdink","year":"2013","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ijrobp.2010.09.006","article-title":"High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a phase II trial","volume":"82","author":"Barkati","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.clon.2017.01.042_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2011.1333","article-title":"Prediction of erectile function following treatment for prostate cancer","volume":"306","author":"Alemozaffar","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clon.2017.01.042_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijrobp.2004.01.024","article-title":"Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate","volume":"59","author":"Luxton","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2017.01.042_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2009.08.011","article-title":"Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer","volume":"93","author":"Wolff","year":"2009","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.042_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.brachy.2010.12.005","article-title":"Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after (125)I prostate permanent seed brachytherapy: a comparative treatment planning study","volume":"10","author":"Zilli","year":"2011","journal-title":"Brachytherapy"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655517300705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655517300705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:43:33Z","timestamp":1760543013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655517300705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0936655517300705"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2017.01.042","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2017.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}